|LCK (Cell-free assay)||Fyn (Cell-free assay)||EGFR (Cell-free assay)||JAK2 (Cell-free assay)||ZAP70 (Cell-free assay)|
|4 nM||5 nM||480 nM||>50 μM||>100 μM|
|In vitro (25°C)||DMSO||60 mg/mL (198.82 mM)|
|Water||<1 mg/mL (<1 mM)|
|Ethanol||2 mg/mL (6.62 mM)|
|In vivo||1% DMSO/30% polyethylene glycol/1% Tween 80||30 mg/mL|
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|0.1 mM||32.18 mL||160.89 mL||321.77 mL|
|0.5 mM||6.44 mL||32.18 mL||64.35 mL|
|1 mM||3.22 mL||16.09 mL||32.18 mL|
|5 mM||0.64 mL||3.22 mL||6.44 mL|
*The above data is based on the productmolecular weight 310.78. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|MECHANISM OF ACTION||Inhibitor|
|Storage||at -20°C 3 years Powder|
|Synonyms||PP-2, PP 2|
TG101209, a novel JAK2 inhibitor, has significant in vitro activity in multiple myeloma and displays preferential cytotoxicity for CD45+ mye…
AC220（Quizartinib）是一种有效的选择性FLT3抑制剂，对于MC4-11和A375，IC50分别为0.56±0.3 nM和> 10 mM。
AZD2932 is a potent and mutil-targeted protein tyrosine kinase inhibitor with IC50 of 8 nM, 4 nM, 7 nM, and 9 nM for VEGFR-2, PDGFRβ, Flt-3…
TG-101348 is an orally bioavailable, ATP-competitive and selective inhibitor of Janus-associated kinase 2 with potential antineoplastic acti…
SGI-1776 free base is a novel ATP competitive inhibitor of Pim1 with IC50 of 7 nM in a cell-free assay, 50- and 10-fold selective versus Pim…
Pexidartinib is a small-molecule receptor tyrosine kinase (RTK) inhibitor of KIT, CSF1R and FLT3 with potential antineoplastic activity.